GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » Short-Term Debt & Capital Lease Obligation

Sysmex (Sysmex) Short-Term Debt & Capital Lease Obligation : $58 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sysmex Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Sysmex's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $58 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Sysmex's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $312 Mil.


Sysmex Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Sysmex's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Short-Term Debt & Capital Lease Obligation Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.95 53.20 54.30 53.49 57.80

Sysmex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.49 58.50 56.22 54.51 57.80

Sysmex Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Sysmex Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sysmex's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (Sysmex) Business Description

Industry
Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (Sysmex) Headlines

From GuruFocus

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan 02-05-2015

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan 02-05-2015

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-04-2017

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood 10-21-2020